Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-21

FDA Approved: LEVETIRACETAM — Original Application (Guardian Drug Company)

View source ↗

Summary

FDA approval of the original abbreviated new drug application for LEVETIRACETAM (Guardian Drug Company) establishing its generic status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

ORIG AP for LEVETIRACETAM (LEVETIRACETAM)